Anti-inflammatory activity of natural coumarin compounds from plants of the Indo-Gangetic plain

Autor: Ramkrishna Ghosh, Partha Sarathi Singha, Lakshmi Kanta Das, Debosree Ghosh, Syed Benazir Firdaus

Publikováno v: AIMS Molecular Science, Vol 10, Iss 2, Pp 79-98 (2023)

Natural compounds are a repertoire of organoleptic molecules. This indicates that although they are not a significant source of nutrients, still they exhibit a wide range of medicinal properties through their plethora of anti-inflammatory and immune-

Externí odkaz: https://doaj.org/article/8e6f961d7786408f90039c0993b06080

Efectividad del tratamiento profiláctico farmacológico en pacientes pediátricos con migraña, una revisión sistemática

Autor: Villalba Guerrero, María Camila

Publikováno v: Alqahtani, M., Barmherzig, R., & Lagman-Bartolome, A. M. (2021). Approach to Pediatric Intractable Migraine. Current Neurology and Neuroscience Reports, 21(8). https://doi.org/10.1007/s11910-021-01128-9
Arias, I., De la Barrera, V., Garrido, A., Mojica, E., Polanía, M., & Villa, M. I. (2021). Banderas rojas en pacientes que consultan por cefalea: conceptos básicos y revisión narrativa de la literatura (Vol. 4, Issue 1). Universidad del Norte.
Candela, R. C., & Fernández, A. H. (2015). Cefalea en el niño y adolescente. Pediatria Integral, 19(9), 632–639.
Casasbuenas, O. (2004). Cefalea en niños. Asociación Colombiana de Neurología, 10(1), 23–33.
Cook, C. (2020). Acute Treatment of Pediatric Migraine: A Review of the Updated Guidelines. Advanced Emergency Nursing Journal, 42(1), 4–12. https://doi.org/10.1097/TME.0000000000000286
Curcó, X. A., & Puñal, J. E. (2013). Cefalea infantil. Anales de Pediatria Continuada, 11(6), 301–311. https://doi.org/10.1016/S1696-2818(13)70152-5
Eiland, L. S. (2007). Anticonvulsant Use for Prophylaxis of the Pediatric Migraine. Journal of Pediatric Health Care, 21(6), 392–395. https://doi.org/10.1016/j.pedhc.2007.08.006
Evers, S., Marziniak, M., Frese, A., & Gralow, I. (2009). Placebo efficacy in childhood and adolescence migraine: An analysis of double-blind and placebo-controlled studies. Cephalalgia, 29(4), 436–444. https://doi.org/10.1111/j.1468-2982.2008.01752.x
Faria, V., Linnman, C., Lebel, A., & Borsook, D. (2014). Harnessing the placebo effect in pediatric migraine clinic. Journal of Pediatrics, 165(4), 659–665. https://doi.org/10.1016/j.jpeds.2014.06.040
Hernández, Fabián, A., de la Vega, I. R. A., & Sánchez, H. G. (2020). Cefalea y migraña en la infancia y adolescencia. Pediatria Integral, 24(7), 393.e1-393.e17.
Hershey, A. D., Powers, S. W., Vockell, A. B., LeCates, S., Kabbouche, M. A., & Maynard, M. K. (2001). PedMIDAS: Development of a questionnaire to assess disability of migraines in children. Neurology, 57(11), 2034–2039.
Jackson, J. L., Shimeall, W., Sessums, L., DeZee, K. J., Becher, D., Diemer, M., & Berbano, E. (2010). Tricyclic antidepressants and headaches systematic reviewand meta-analysis.pdf. BMJ, 341, 1–13.
Khrizman, M., & Pakalnis, A. (2018). Management of pediatric migraine: Current therapies. Pediatric Annals, 47(2), e55–e60. https://doi.org/10.3928/19382359-20180129-02
Lewis, D., Ashwal, S., Hershey, A., Hirtz, D., Yonker, M., & Silberstein, S. (2004). Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents [RETIRED]. In Neurology (Vol. 63, Issue 12, pp. 2215–2224). https://doi.org/10.1212/01.wnl.0000147332.41993.90
Lewis, D. W. (2009). Pediatric Migraine. Neurologic Clinics, 27(2), 481–501. https://doi.org/10.1016/j.ncl.2008.11.003
Loreto, M. (2014). Headaches, Assessment and Initial Management. Rev.Med.Clin.Condes, 25(4), 651–657.
Olesen, J. (2018). Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202
Oskoui, M., Pringsheim, T., Billinghurst, L., Potrebic, S., Gersz, E. M., Gloss, D., Holler-Managan, Y., Leininger, E., Licking, N., Mack, K., Powers, S. W., Sowell, M., Victorio, M. C., Yonker, M., Zanitsch, H., & Hershey, A. D. (2020). Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention. In Neurology (Vol. 94, Issue 1, pp. 50.2-50). https://doi.org/10.1212/wnl.0000000000008750
Sampaio Rocha-Filho, P. A., & Hershey, A. D. (2017). Pediatric Migraine Disability Assessment (PedMIDAS): Translation Into Brazilian Portuguese and Cross-Cultural Adaptation. Headache, 57(9), 1409–1415. https://doi.org/10.1111/head.13159
Santos Lasaosa, S., Rosich, P. P., Nieto, R. B., Latorre González, G., & González Oria, C. (2020). Manual de Práctica Clínica en Cefaleas. Recomendaciones. In Manual de Práctica Clínica en Cefaleas. Recomendaciones Diagnóstico-Terapéuticas de la Sociedad Española de Neurología 2020.
Sterling, T. D., Rosenbaum, W. L., & Weinkam, J. J. (1995). Publication decisions revisited: The effect of the outcome of statistical tests on the decision to publish and vice versa. American Statistician, 49(1), 108–112. https://doi.org/10.1080/00031305.1995.10476125
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

Introducción: la migraña es una de las cefaleas primarias más importantes en la población pediátrica; su tratamiento se basa en el tratamiento agudo y el tratamiento profiláctico que incluye medidas farmacológicas y no farmacológicas. Aún no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dad8cc91b16904656804b009f78e3b5a
https://repository.urosario.edu.co/handle/10336/34542

Effects of remifentanil on human C20 microglial pro-inflammatory activation

Autor: N, Cappoli, P, Aceto, E, Tabolacci, D, Mezzogori, L, Sollazzi, P, Navarra, C, Dello Russo

Remifentanil (RF) is a potent short-acting μ-opioid receptor agonist. Although preferred for its unique pharmacokinetics, the clinical use may be limited by hyperalgesia. Preclinical studies have shown a potential role of microglia on the developmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::645a75d4d7af562309f69ec5d6b88f2c
http://hdl.handle.net/10807/193277

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Perfil socioeconômico, epidemiológico e farmacoterapêutico de idosos institucionalizados de Brasília, Brasil The socio-economic, epidemiological and pharmaco-therapeutic profile of institutionalized elderly individuals in Brasilia, Brazil

Autor: Maria Rita Carvalho Garbi Novaes, Mirna Poliana Furtado de Oliveira

Publikováno v: Ciência & Saúde Coletiva, Vol 18, Iss 4, Pp 1069-1078 (2013)

O objetivo deste estudo é descrever o perfil socioeconômico, epidemiológico e farmacoterapêutico de 154 idosos de cinco Instituições de Longa Permanência de Brasília por meio de questionário adaptado do Método Dáder e complementado com inf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::c95cd1f5fbc23bfdc1a2b7cbf656f1d4
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232013001000020